DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination

Nature Nanotechnology

Volumn 9, Issue 2, 2014, Pages 148-155

  Chou, Leo Y T ^a   Zagorovsky, Kyryl ^a   Chan, Warren C W ^a,b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Department of Chemical Engineering ^*  (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARCHITECTURAL DESIGN; DNA; MEDICAL NANOTECHNOLOGY; SURFACE CHEMISTRY;

BIOLOGICAL APPLICATIONS; COMPLEX NANOSTRUCTURES; ENZYMATIC DEGRADATION; INDIVIDUAL NANOPARTICLES; INORGANIC NANOPARTICLE; NANOPARTICLE SUPERSTRUCTURES; NANOSTRUCTURE INTERACTIONS; THERAPEUTIC AGENTS;

NANOPARTICLES;

DNA; GOLD NANOPARTICLE; NANOMATERIAL; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA SEQUENCE; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; FLUORESCENCE IMAGING; FLUORESCENCE SPECTROSCOPY; MACROPHAGE; MOUSE; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PARTICLE SIZE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; URINARY EXCRETION; CHEMICAL STRUCTURE; ENZYMATIC DEGRADATION; EXOCYTOSIS;

ANIMALS; DNA; DRUG DELIVERY SYSTEMS; EXOCYTOSIS; MACROPHAGES; MICE; MICE, NUDE; NANOMEDICINE; NANOPARTICLES; NANOSTRUCTURES; NEOPLASMS;

EID: 84893767674     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2013.309     Document Type: Article

References (34)

1. Kim, J., Piao, Y. & Hyeon, T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev. 38, 372-390 (2009).
2. Giljohann, D. A. et al. Gold nanoparticles for biology and medicine. Angew. Chem. Int. Ed. 49, 3280-3294 (2010).
3. Gao, J., Gu, H. & Xu, B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc. Chem. Res. 42, 1097-1107 (2009).
4. Smith, A. M., Duan, H., Mohs, A. M. & Nie, S. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv. Drug Deliv. Rev. 60, 1226-1240 (2008).
5. Jiang, W., Kim, B. Y. S., Rutka, J. T. & Chan, W. C. W. Nanoparticle-mediated cellular response is size-dependent. Nature Nanotech. 3, 145-150 (2008).
6. Albanese, A., Tang, P. S. & Chan, W. C. W. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14, 1-16 (2012).
7. Petros, R. A. & DeSimone, J. M. Strategies in the design of nanoparticles for therapeutic applications. Nature Rev. Drug Discov. 9, 615-627 (2010).
8. Davis, M. E., Chen, Z. & Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Rev. Drug Discov. 7, 771-782 (2008).
9. Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C. & Chan, W. C. W. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 9, 1909-1915 (2009).
10. Robinson, J. T. et al. In vivo fluorescence imaging in the second near-infrared window with long circulating carbon nanotubes capable of ultrahigh tumor uptake. J. Am. Chem. Soc. 134, 10664-10669 (2012).
11. Park, J. H. et al. Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc. Natl Acad. Sci. USA 107, 981-986 (2010).
12. Choi, H. S. et al. Renal clearance of quantum dots. Nature Biotechnol. 25, 1165-1170 (2007).
13. Zhou, C., Long, M., Qin, Y., Sun, X. & Zheng, J. Luminescent gold nanoparticles with efficient renal clearance. Angew. Chem. Int. Ed. 50, 3168-3172 (2011).
14. Ballou, B. et al. Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjug. Chem. 18, 389-396 (2007).
15. Albanese, A. & Chan, W. C. W. Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano 5, 5478-5489 (2011).
16. Diáz, B. et al. Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. Small 4, 2025-2034 (2008).
17. Lovrić, J., Cho, S. J., Winnik, F. M. & Maysinger, D. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem. Biol. 12, 1227-1234 (2005).
18. Derfus, A. M., Chan, W. C. W. & Bhatia, S. N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 4, 11-18 (2004).
19. Yang, R. S. H. et al. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ. Health Perspect. 115, 1339-1343 (2007).
20. Kim, J. S. et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci. 89, 338-347 (2006).
21. Ye, L. et al. A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots. Nature Nanotech. 7, 453-458 (2012).
22. Choi, H. S. et al. Design considerations for tumour-targeted nanoparticles. Nature Nanotech. 5, 42-47 (2010).
23. Yoon, J., Lim, J. & Yoon, S. Controlled assembly and plasmonic properties of asymmetric core-satellite nanoassemblies. ACS Nano 6, 7199-7208 (2012).
24. Xu, X., Rosi, N. L., Wang, Y., Huo, F. & Mirkin, C. A. Asymmetric functionalization of gold nanoparticles with oligonucleotides. J. Am. Chem. Soc. 128, 9286-9287 (2006).
25. Knop, K., Hoogenboom, R., Fischer, D. & Schubert, U. S. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. 49, 6288-6308 (2010).
26. Chaires, J., Herrera, J. & Waring, M. Preferential binding of daunomycin to 5'TACG and 5'TAGC sequences revealed by footprinting titration experiments. Biochemistry 29, 6145-6153 (1990).
27. Owens, D. E. & Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307, 93-102 (2006).
28. Khlebtsov, N. & Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 40, 1647-1671 (2011).
29. Clift, M. J. D. et al. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol. Appl. Pharmacol. 232, 418-427 (2008).
30. He, C., Hu, Y., Yin, L., Tang, C. & Yin, C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31, 3657-3666 (2010).
31. Patel, P. C. et al. Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles. Bioconjug. Chem. 21, 2250-2256 (2010).
32. Claus, V. et al. Lysosomal enzyme trafficking between phagosomes, endosomes, and lysosomes in J774 macrophages. Enrichment of cathepsin H in early endosomes. J. Biol. Chem. 273, 9842-9851 (1998).
33. Odaka, C. & Mizuochi, T. Role of macrophage lysosomal enzymes in the degradation of nucleosomes of apoptotic cells. J. Immunol. 163, 5346-5352 (1999).
34. Chou, L. Y. T. & Chan, W. C. W. Fluorescence-tagged gold nanoparticles for rapidly characterizing the size-dependent biodistribution in tumor models. Adv. Healthcare Mater. 1, 714-721 (2012).